How the hunger for a new weight loss drug is feeding an industry of fakes
Counterfeit versions of a drug which is still in clinical trials are flooding the black market.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
""The world has gone mad," pharmacist and director of 24 HR Pharmacy, Sehar Shahid says."
— Sehar Shahid , Executive
""Young fit patients are coming into hospital with nausea, vomiting, diarrhoea, in some cases kidney failure," says endocrinologist, Prof Donal O'Shea."
— Prof Donal O'Shea , Academic
""It was horrendous," says the 20-year-old from Brighton."
— Tom Davies , Academic
Key People
Locations
All Coverage
Counterfeit versions of a drug which is still in clinical trials are flooding the black market.
Similar Stories
Related coverage based on topic and tags
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial - reuters.com
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial reuters.com
September 30, 2026 at 10:30 PMExperimental Lilly combination drug tops Zepbound in weight-loss trial - Reuters
Experimental Lilly combination drug tops Zepbound in weight-loss trial Reuters
September 30, 2026 at 05:34 PMPatients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study - Reuters
Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study Reuters
September 30, 2026 at 09:57 AMLilly's experimental drug cuts weight by 21% in diabetes trial - reuters.com
Lilly's experimental drug cuts weight by 21% in diabetes trial reuters.com
September 29, 2026 at 10:15 PMIndia orders crackdown on nicotine pouches, citing health risks, letter shows - Reuters
India orders crackdown on nicotine pouches, citing health risks, letter shows Reuters
September 25, 2026 at 11:03 AM'Super' El Niño could cause 451,000 excess deaths, researchers say - reuters.com
'Super' El Niño could cause 451,000 excess deaths, researchers say reuters.com
September 23, 2026 at 03:27 PM